BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. World J Gastroenterol 2015; 21(21): 6649-6659 [PMID: 26074703 DOI: 10.3748/wjg.v21.i21.6649]
URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6649.htm
Number Citing Articles
1
Cem Cengiz, Safak Bulut, A. Sedat Boyacioglu, M. Ayhan Kuzu. Nerve/Glial Antigen 2: A Novel Target for Anti-Tumor Therapy in Colorectal CancerDigestion 2017; 96(1): 60 doi: 10.1159/000478853
2
Joana G. Rodrigues, Meritxell Balmaña, Joana A. Macedo, Juliana Poças, Ângela Fernandes, Julio Cesar M. de-Freitas-Junior, Salomé S. Pinho, Joana Gomes, Ana Magalhães, Catarina Gomes, Stefan Mereiter, Celso A. Reis. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasisCellular Immunology 2018; 333: 46 doi: 10.1016/j.cellimm.2018.03.007
3
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier, François Bertucci. CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune ResponseCancers 2022; 14(5): 1306 doi: 10.3390/cancers14051306
4
Le Yang, Hang Zhang, Chengbin Dong, Wenhui Yue, Renmin Xue, Fuquan Liu, Lin Yang, Liying Li. Neuron-Glial Antigen 2 Participates in Liver Fibrosis via Regulating the Differentiation of Bone Marrow Mesenchymal Stem Cell to MyofibroblastInternational Journal of Molecular Sciences 2023; 24(2): 1177 doi: 10.3390/ijms24021177
5
Alexandra Y Tsidulko, Galina M Kazanskaya, Diana V Kostromskaya, Svetlana V Aidagulova, Roman S Kiselev, Alexandr M Volkov, Vyacheslav V Kobozev, Alexei S Gaitan, Alexei L Krivoshapkin, Elvira V Grigorieva. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastomaTumor Biology 2017; 39(9): 101042831772428 doi: 10.1177/1010428317724282
6
Zoi Piperigkou, Benedikt Mohr, Nikos Karamanos, Martin Götte. Shed proteoglycans in tumor stromaCell and Tissue Research 2016; 365(3): 643 doi: 10.1007/s00441-016-2452-4
7
Hongyu Zhang, Zhenyu Wu, Deyu Hu, Min Yan, Jing Sun, Jiejuan Lai, Lianhua Bai. Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ CancersVaccines 2022; 10(7): 1023 doi: 10.3390/vaccines10071023
8
Laurys Boudin, A de Nonneville, Pascal Finetti, Léna Mescam, A Le Cesne, Antoine Italiano, Jean-Yves Blay, Daniel Birnbaum, Emilie Mamessier, François Bertucci. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune responseJournal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03679-y
9
Tomohiro KUROKAWA, Kohzoh IMAI. Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapyProceedings of the Japan Academy, Series B 2024; 100(5): 293 doi: 10.2183/pjab.100.019
10
May-Britt Firnau, Angela Brieger. CK2 and the Hallmarks of CancerBiomedicines 2022; 10(8): 1987 doi: 10.3390/biomedicines10081987
11
Ruhi Gulati, Maggie Lutz, Margaret Hanlon, Ashley Cast, Rebekah Karns, James Geller, Alex Bondoc, Gregory Tiao, Lubov Timchenko, Nikolai A. Timchenko. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastomaHepatology Communications 2024; 8(2) doi: 10.1097/HC9.0000000000000369
12
Georgios-Ioannis Verras, Levan Tchabashvili, David-Dimitris Chlorogiannis, Francesk Mulita, Maria-Ioanna Argentou. Updated Clinical Evidence on the Role of Adipokines and Breast Cancer: A ReviewCancers 2023; 15(5): 1572 doi: 10.3390/cancers15051572